Your browser doesn't support javascript.
loading
Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.
Hietikko, Ronja; Kilpeläinen, Tuomas P; Kenttämies, Anu; Ronkainen, Johanna; Ijäs, Kirsty; Lind, Kati; Marjasuo, Suvi; Oksala, Juha; Oksanen, Outi; Saarinen, Tuomas; Savolainen, Ritja; Taari, Kimmo; Tammela, Teuvo L J; Mirtti, Tuomas; Natunen, Kari; Auvinen, Anssi; Rannikko, Antti.
Afiliación
  • Hietikko R; Department of Urology, University of Helsinki and Helsinki University Hospital, PL900, 00029 HUS, Helsinki, Finland. Ronja.hietikko@hus.fi.
  • Kilpeläinen TP; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Ronja.hietikko@hus.fi.
  • Kenttämies A; Department of Urology, University of Helsinki and Helsinki University Hospital, PL900, 00029 HUS, Helsinki, Finland.
  • Ronkainen J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Ijäs K; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Lind K; HUS Diagnostic Center, HUS Medical Imaging Center / Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Marjasuo S; Department of Radiology, Tampere University Hospital, Tampere, Finland.
  • Oksala J; HUS Diagnostic Center, HUS Medical Imaging Center / Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Oksanen O; HUS Diagnostic Center, HUS Medical Imaging Center / Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Saarinen T; HUS Diagnostic Center, HUS Medical Imaging Center / Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Savolainen R; Department of Radiology, Tampere University Hospital, Tampere, Finland.
  • Taari K; HUS Diagnostic Center, HUS Medical Imaging Center / Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Tammela TLJ; Department of Radiology, Tampere University Hospital, Tampere, Finland.
  • Mirtti T; HUS Diagnostic Center, HUS Medical Imaging Center / Radiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Natunen K; Department of Urology, University of Helsinki and Helsinki University Hospital, PL900, 00029 HUS, Helsinki, Finland.
  • Auvinen A; Department of Urology, Tampere University Hospital, Tampere, Finland.
  • Rannikko A; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Cancer Imaging ; 20(1): 72, 2020 Oct 09.
Article en En | MEDLINE | ID: mdl-33036660
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Imagen por Resonancia Magnética Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Imagen por Resonancia Magnética Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Finlandia